Summary
A clinical-pharmacological study was performed to determine the effect of acetylsalicylic acid upon the serum concentration of indomethacin. 14 rheumatic patients were given indomethacin orally (25 mg × 4 for 4 days) and concurrently acetylsalicylic acid 3.7 g orally (0.9 g × 3 and 1.0 g × 1 daily), and 21 rheumatic patients were given indomethacin rectally in the morning (100 mg × 1) and concurrently acetylsalicylic acid 3.7 g orally (0.9 g × 3 and 1.0 g × 1 daily). On comparison with treatment with oral or rectal indomethacin alone, it was found that peak serum concentrations of indomethacin were significantly reduced (1% level), the times of the peaks were not shifted, and the areas beneath the serum concentration curves of indomethacin were smaller, but significantly so only if compared with rectal administration. In 12 rheumatic patients given indomethacin by rectum in the evening (100 mg × 1) and concurrently acetylsalicylic acid 3.7 g (0.9 g × 3 and 1.0 g × 1 daily), the serum level of indomethacin on the following morning (after 11 h) did not differ from that found after rectal treatment. A statistically but not biologically significant difference was observed between the mean serum half-lives of indomethacin given orally and rectally. For unknown reasons, concurrent doses of acetylsalicylic acid and indomethacin made the mean serum half-life of indomethacin longer than after its oral administration, but shorter than when the same dose of indomethacin was given rectally. There was no difference between serum levels of salicylate after oral administration of acetylsalicylic acid alone or after a concurrent oral or rectal dose of indomethacin. The results have been related to those reported previously, with respect to the interaction between indomethacin and acetylsalicylic acid, the serum levels of indomethacin after oral and rectal dosing, and the serum half-life of indomethacin based upon a one- or two-compartment model. The clinical relevance of the study is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alván, G., Bertilsson, L., Holmstedt, B., Orme, M., Palmér, L., Sjöqvist, F.: Indomethacins kinetik efter engångsdoser studerad med en ny massfragmentografisk metod. Medicinska Riksstämman abstracts, p. 159, Stockholm: Svenska Läkaresällskapet 1973
Arnold, E., Brynger, H.: Serumkoncentrationsmätningar efter administration av indometacin kapslar och suppositorier. Opusc. med. (Stockh.)15, 333–336 (1970)
Champion, G.D., Paulus, H.E., Mongan, E., Okun, R., Pearson, C.M., Sarkissian, E.: The effect of aspirin on serum indomethacin. Clin. Pharmacol. Ther.13, 239–244 (1972)
Documenta Geigy Wissenschaftliche Tabellen, 6. Auflage, pp. 124–127. J.R. Geigy A.G., Pharmazeutische Abteilung (1960)
Duggan, D.E., Hogans, A.F., Kwan, K.C., McMahon, F.G.: The metabolism of indomethacin in man. J. Pharmacol. exp. Ther.181, 563–575 (1972)
Garnham, J.C., Raymond, K., Shotton, E., Turner, P.: The availability of indomethacin and the effect of concurrent administration of aspirin on blood levels in man. 33rd International Congress of Pharmaceutical Sciences. Abstracts, p. 169, Stockholm 1973
Holt, L.P.J., Hawkins, C.F.: Indomethacin: studies of absorption and of the use of indomethacin suppositories. Brit. med. J.1965 I, 1354–1356
Hucker, H.B., Zacchei, A.G., Cox, S.V., Brodie, D.A., Cantwell, N.H.R.: Studies on the absorption, distribution and excretion of indomethacin in various species. J. Pharmacol. exp. Ther.153, 237–249 (1966)
Hvidberg, E., Lausen, H.H., Jansen, J.A.: Indomethacin: plasma concentrations and protein binding in man. Europ. J. clin. Pharmacol.4, 119–124 (1972)
Jeremy, R., Towson, J.: Interaction between aspirin and indomethacin in the treatment of rheumatoid arthritis. Med. J. Austral.2, 127–129 (1970)
Levy, G., Tsuchiya, T.: Salicylate accumulation kinetics in man. New Engl. J. Med.287, 430–432 (1972)
Lindquist, B., Møller Jensen, K., Johansson, H., Hansen, T.: Concurrent administration of acetylsalicylic acid and indomethacin. Effect on blood levels. Clin. Pharmacol. Ther.15, 247–252 (1974)
O'Brien, W.: Indomethacin: a survey of clinical trials. Clin. Pharmacol. Ther.9, 94–107 (1968)
Prescott, L.F.: Antipyretic analgesics and drugs used in rheumatic diseases and gout. In: Meyler, L., Herxheimer, A.: Side effects of drugs. Amsterdam: Excerpta Medica,7, 138–185 (1972)
Prescott, L.F.: Clinically important drug interactions. Med. Progress1, 47–62 (1974)
Russell, A.S., Sturge, R.A., Smith, M.A.: Serum transaminases during salicylate therapy. Brit. med. J.1971 II, 428–429
The Cooperation Clinics Committee of the American Rheumatism Association: A three-months trial of indomethacin in rheumatoid arthritis, with special reference to analysis and interference. Clin. Pharmacol. Ther.8, 11–37 (1967)
Yesair, D.W., Callahan, M., Remington, L., Kensler, C.J.: Comparative effects of salicylic acid, phenylbutazone, probenecid and other anions on the metabolism, distribution and excretion of indomethacin by rats. Biochem. Pharmacol.19, 1591–1600 (1970)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaldestad, E., Hansen, T. & Brath, H.K. Interaction of indomethacin and acetylsalicylic acid as shown by the serum concentrations of indomethacin and salicylate. Eur J Clin Pharmacol 9, 199–207 (1975). https://doi.org/10.1007/BF00614018
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00614018